Science Explorer Back to mapMap
Discussion
Researcher · Universidad de Oviedo · Spain

Xosé S. Puente

Xosé S. Puente publishes mostly in Molecular Biology, Cancer Research and Genetics, on topics such as Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics and Lymphoma Diagnosis and Treatment.

ORCID 0000-0001-9525-1483 OpenAlex
World rank
#19,643
of 7,710,434 ranked researchers
Rank in Spain
#162
of 204,306
Works
273
Citations
48k
Citations per work
176.6
h-index
79
i10-index 141Top 0.7% in Molecular Biology
Xosé S. Puente

What does Xosé S. Puente research?

Xosé S. Puente's work is mostly in Biochemistry, Genetics and Molecular Biology (48%), Medicine (28%).

Life Sciences: 130 works · 47.6% of their workBiochemistry, Genetics and Molecular Biology: 130 works · 47.6% of their workMolecular Biology: 73 works · 26.7% of their workCancer Research: 39 works · 14.4% of their workGenetics: 18 works · 6.5% of their workHealth Sciences: 77 works · 28.2% of their workMedicine: 77 works · 28.2% of their workGenetics: 31 works · 11.3% of their workPathology and Forensic Medicine: 27 works · 9.8% of their workOncology: 19 works · 7.1% of their workEverything else: 66 works · 24.2% of their workTHEIR WORKXosé S. Puente273works
Life Sciences48%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology13047.6%
    1. Medicine7728.2%
  3. Everything else6624.2%
  1. 1Molecular Biology27% of their works
  2. 2Cancer Research14% of their works
  3. 3Genetics11% of their works
  4. 4Pathology and Forensic Medicine10% of their works
  5. 5Oncology7% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Xosé S. Puente's research?

The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, PET Imaging, Cancer Genomics, Mutational Signatures, Angiogenesis and Classification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab862 topics
  2. Chronic Lymphocytic Leukemia571 topic
  3. Genomic Aberrations571 topic
  4. PET Imaging442 topics
  5. Cancer Genomics431 topic
  6. Mutational Signatures431 topic
  7. Angiogenesis412 topics
  8. Classification291 topic
  9. Lymphoma291 topic
  10. Matrix Metalloproteinases261 topic
  11. Tissue Inhibitors of Metalloproteinases261 topic
  12. Microsatellite Instability231 topic
  13. Molecular Characterization231 topic
  14. Alternative Splicing151 topic
  15. Fibroblast Activation Protein151 topic
  16. Genetic Mutations151 topic
  17. Primary Immunodeficiency151 topic
  18. RNA-Binding Proteins151 topic
  19. Tumor Microenvironment151 topic

Where does Xosé S. Puente work?

Xosé S. Puente's main affiliation in the publication record is Universidad de Oviedo, Spain.

How many publications and citations does Xosé S. Puente have?

OpenAlex counts 273 works and 48,206 citations for Xosé S. Puente, an h-index of 79, ranking #19,643 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Xosé S. Puente. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.